Who owns ABVC BIOPHARMA INC?
- Ticker: ABVC
- CUSIP Number: 00091f304
Tip: Access positions for across all investors
Analyze quarterly positions in Abvc Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Abvc Biopharma stock
Who bought or sold ABVC BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 268k | $813k | 140% | Sep 2025 |
|
| Geode Capital Management | 188k | $571k | 70% | Sep 2025 |
|
| Renaissance Technologies | 111k | $336k | 165% | Sep 2025 |
|
| State Street Corporation | 73k | $221k | 464% | Sep 2025 |
|
| BlackRock | 56k | $172k | 100% | Sep 2025 |
|
| Northern Trust | 25k | $76k | -33% | Sep 2025 |
|
| XTX Topco | 25k | $75k | -53% | Sep 2025 |
|
| Millennium Management | 20k | $60k | 100% | Sep 2025 |
|
| Citadel Advisors | 16k | $48k | 100% | Sep 2025 |
|
| Tower Research Capital | 2.2k | $6.6k | 509% | Sep 2025 |
|
| UBS Group | 1.8k | $5.6k | 100% | Sep 2025 |
|
| Simplex Trading | 1.1k | $3.0k | 100% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 150.00 | $456.000000 | 100% | Sep 2025 |
|
Who sold out of Abvc Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| SBI Securities | Jun 2025 | 483.00 | $1.1k |